April 13, 2026
(MIT Technology Review) – Companies are playing word games with promising cancer treatments. In its formal communications, like regulatory filings, Moderna hasn’t called the shot a cancer vaccine since 2023. That’s when it partnered up with Merck and rebranded the … Read More
April 10, 2026
(Comment) – There is, of course, something a bit ridiculous to this whole scene: the “ideal” measurements for girls and boys at each month calculated down to the inch, the doctors with clipboards, the very concept of the most “scientific” … Read More
April 9, 2026
(The Atlantic) – In desperation, the woman’s care team reached out to Müller, a hematologist-oncologist at the University Hospital of Erlangen, a roughly three-hour drive away by ambulance. In recent years, he and his colleagues have made a name for … Read More
April 8, 2026
(Nature) – Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from GLP-1 medications. Scientists have identified a set of genetic variants that could help to explain why responses to obesity drugs … Read More
April 8, 2026
(Wired) – The trial focused on tumor types where HER3 signaling is implicated. HER3 is a membrane-bound protein that mediates cell-to-cell communication on growth and division. But when cancer is present, HER3 signaling can act as a pro-cancer driver, contributing … Read More
March 30, 2026
(NYT) – The decision is the most significant since Kirsty Coventry was elected last year to serve as president of the I.O.C. Under the new policy eligibility will be determined by a one-time gene test, according to the I.O.C. The … Read More
March 27, 2026
(New Scientist) – A 20-year study has shown that, like photocopying photocopies, cloning doesn’t produce perfect copies – with big implications for farming, conservation and de-extinction A clone is meant to be a genetically identical copy, but an extraordinary 20-year … Read More
March 17, 2026
(Wired) – Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. SMaRT, located in Suita City, Osaka Prefecture, is responsible for the … Read More
March 9, 2026
(The Times) – Documentary maker Rebecca Coxon uploaded her genetic data to an ancestry website on a whim. The results would be just the beginning of a decade questioning everything she thought she knew about family and motherhood But in … Read More
February 25, 2026
(NPR) – The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new guidance would enable the agency to … Read More
February 23, 2026
(San Diego Union-Tribune) – Element Biosciences unveiled a device that can read DNA for half the price of Illumina’s technology. Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price … Read More
February 18, 2026
(Science Daily) – Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes … Read More
February 16, 2026
(The Atlantic) – Sid now works on a rare-disease program within the National Institutes of Health. Since he first found out that he was a carrier for thalassemia, he told me, research has shown that people like him can experience … Read More
February 12, 2026
(MedPage Today) – Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol. It’s very early stage research, tried in only a few dozen people so far. … Read More
January 30, 2026
(NBC News) – A person’s genes play a far greater role in likely lifespan than previously thought, according to a major new study published Thursday in the journal Science. Using data from human twin studies, an international team of researchers … Read More
January 29, 2026
(New York Times) – AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. Scientists used the program to study how proteins normally work — … Read More
January 28, 2026
(MIT Technology Review) – In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. ER-100 turns out to be the code name of a treatment created by Life Biosciences, a small Boston startup … Read More
January 23, 2026
(Plough) – Our son Yusang has Down syndrome. He saved another child’s life. My wife and I had just learned that a couple from our church were wrestling with grief and confusion, so that cold Sunday evening, I set out … Read More
January 22, 2026
(New York Times) – He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for researchers who push boundaries. For creating the world’s first genetically edited babies, He Jiankui has … Read More
January 20, 2026
(NPR) – In May, Cole completed a several-months-long gene therapy treatment that helps reprogram the body’s stem cells to produce healthy red blood cells. She was one of the first Medicaid enrollees nationally to benefit from a new payment model … Read More
January 16, 2026
(Washington Post via MSN) – A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric patients, finding that many conditions involve similar genes and may not need to be treated as … Read More
January 14, 2026
(Washington Post via MSN) – Therapies that target genetic illnesses at their root are no longer on the horizon. They are here. More are coming. But even as a growing suite of gene therapy tools are changing individual patients’ lives, … Read More
January 13, 2026
(MIT Technology Review) – Genetic testing on embryos is more sophisticated and accessible than ever—and it’s now being sold as a way to let parents pick their future baby’s best traits. Many Americans agree that it’s acceptable to screen embryos … Read More
January 9, 2026
(Wired) – Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February, a sick infant named KJ received a gene-editing treatment made … Read More
January 9, 2026
(MIT Technology Review) – Aurora Therapeutics’ first target is the rare inherited disease phenylketonuria, also known as PKU. It’s becoming clear that the impact of CRISPR isn’t as big as we all hoped. In fact, there’s a pall of discouragement … Read More
